SIGN UP TO VIEW THE FULL ARTICLE

Receive a 90-day free trial of Celltelligence and get instant access to our full offering.

EMAIL BLASTS

Curated cell therapy industry news in your inbox multiple times each week

SEARCHABLE LIBRARY

A full archive of cell therapy news, insights, and context

THE MAP

A 24/7 information center that lets you make unique connections

The price for access is $0.00.

Do you have a discount code? Click here to enter your discount code.

Account Information

Username

Password

Confirm Password

Work E-mail Address

Confirm E-mail Address

Occupation

Other

Full Name LEAVE THIS BLANK

Payment Information We accept all major credit cards

Card Number

Expiration Date

CVC

Discount Code

I want to receive updates from celltelligence.com.

By selecting this, I agree to receive emails from celltelligence.com.

Processing...

Already have an account? Log in here

RETURN TO HOME

Allogeneic, Autologous, CAR-T

January 12, 2023

JPM 2023 Analysis Day 3: Century Tx, Atara Bio, and Precigen

Here is a brief preview of this blast: On the third day of the JPM 2023, Celltelligence covered presentations by Century Tx (press release / webcast / presentation), Atara Bio (webcast / presentation), and Precigen (press release / presentation). Below, Celltelligence provides insights and context for each presentation. The following topics are covered below.